NCT07159412View on ClinicalTrials.gov

Huazhi Rougan Granule as an Add-On Therapy for H. Pylori Infection With Metabolic-associated Steatohepatitis

NANot yet recruitingINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Helicobacter Pylori InfectionMetabolic-associated SteatohepatitisHigh-dose Dual TherapyHuazhi Rougan Granule
Interventions
DRUG

Vonoprazan-amoxicillin combined with Huazhi Rougan Granule

Vonoprazan-amoxicillin dual therapy combined with Huazhi Rougan Granule

DRUG

Vonoprazan-amoxicillin combined with Huazhi Rougan Granule placebo

Vonoprazan-amoxicillin dual therapy combined with Huazhi Rougan Granule placebo

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT07159412 - Huazhi Rougan Granule as an Add-On Therapy for H. Pylori Infection With Metabolic-associated Steatohepatitis | Biotech Hunter | Biotech Hunter